US Stock MarketDetailed Quotes
ALPMY Astellas Pharma (ADR)
- 11.710
- +0.050+0.43%
15min DelayClose Nov 4 16:00 ET
- 11.710
- 0.0000.00%
Post 16:02 ET
20.96BMarket Cap54.47P/E (TTM)
11.730High11.660Low88.14KVolume11.660Open11.660Pre Close1.03MTurnover0.01%Turnover Ratio188.87P/E (Static)1.79BShares13.14052wk High2.01P/B20.96BFloat Cap9.15052wk Low0.24Dividend TTM1.79BShs Float18.789Historical High2.02%Div YieldTTM0.60%Amplitude0.508Historical Low11.698Avg Price1Lot Size
Astellas Pharma (ADR) Key Stats
Quarterly+Annual
YOY
| (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | ||||||||||
| Net income from continuing operations | 7.78%50.5B | -81.14%24.97B | -1.64%-48.66B | -64.10%21.45B | -94.00%5.33B | 47.89%46.85B | -15.63%132.36B | -355.28%-47.88B | -23.70%59.76B | 66.75%88.8B |
| Other non cash items | 86.06%-2.8B | -64.23%35.37B | -71.38%18.34B | -45.01%16.2B | 231.80%20.87B | -194.84%-20.05B | 654.16%98.86B | 999.58%64.09B | 203.15%29.47B | -169.91%-15.83B |
| Change In working capital | -18.11%-49.07B | -257.38%-86.52B | -85.31%4.03B | -42.17%-26.17B | -655.33%-22.83B | -37.57%-41.55B | -506.46%-24.21B | 420.28%27.42B | -351.94%-18.41B | -116.54%-3.02B |
| -Change in receivables | -419.87%-26.79B | -1,053.80%-55.95B | -170.98%-24.04B | -3.54%-25.61B | -629.79%-14.67B | 150.00%8.37B | 39.40%-4.85B | 248.93%33.87B | -455.54%-24.74B | -58.90%2.77B |
| -Change in inventory | 104.71%790M | -747.25%-60.04B | -58.45%-15.42B | -730.77%-15.99B | -196.65%-11.87B | -507.39%-16.76B | -129.45%-7.09B | -243.23%-9.73B | 37.85%2.54B | -155.81%-4B |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 3.30%12.6B | -47.38%172.48B | -37.73%71.98B | -28.90%51.41B | -59.48%36.88B | -75.02%12.2B | 27.32%327.77B | 137.92%115.59B | 4.09%72.32B | -8.34%91.03B |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | ||||||||||
| Net PPE purchase and sale | -39.11%-14B | -4.43%-38.06B | 6.39%-10.53B | 34.43%-7.47B | -79.69%-9.99B | -22.19%-10.06B | -18.55%-36.44B | -7.12%-11.25B | -315.08%-11.4B | 31.70%-5.56B |
| Net intangibles purchase and sale | -93.45%-9.63B | 35.56%-33.44B | 44.30%-9.4B | 19.58%-7.48B | 26.99%-11.59B | 49.47%-4.98B | -142.15%-51.89B | -153.79%-16.87B | -159.61%-9.3B | 19.95%-15.87B |
| Net business purchase and sale | ---- | ---784.97B | ---190M | ---24.73B | ---- | ---- | --0 | --0 | --0 | ---- |
| Net investment purchase and sale | ---- | --0 | --0 | --0 | ---- | ---- | 126.40%12.62B | -90.67%456M | -73.77%64M | ---- |
| Net other investing changes | -1,410.04%-17.36B | 113.60%1.82B | -287.31%-4.62B | 69.66%-2.29B | 206.84%7.4B | 198.73%1.33B | 15.85%-13.35B | 190.46%2.47B | -45.56%-7.55B | 5.04%-6.93B |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -219.91%-39.35B | -900.95%-845.8B | 2.47%-22.16B | -48.64%-40.31B | -4,869.27%-771.03B | 35.75%-12.3B | -35.39%-84.5B | -53.23%-22.72B | -432.45%-27.12B | 55.23%-15.52B |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | ||||||||||
| Net issuance payments of debt | -72.16%65.14B | 5,241.55%771.23B | 186.23%43.12B | -134.46%-17.23B | 1,804.48%511.35B | 1,460.00%234B | 75.00%-15B | -150.00%-50B | --50B | 25.00%-30B |
| Net common stock issuance | 35.17%-6.96B | 82.27%-10.74B | 100.00%-1M | 0.00%-2M | ---1M | -1.69%-10.73B | -19.40%-60.56B | 0.00%-50B | -100.00%-2M | --0 |
| Cash dividends paid | -16.43%-62.76B | -16.24%-116.65B | --0 | -14.76%-62.75B | --0 | -18.01%-53.9B | -17.74%-100.36B | --0 | -18.04%-54.68B | --0 |
| Net other financing activities | -328.43%-4.46B | -414.11%-16.54B | -846.38%-8.9B | -307.75%-3.79B | -322.52%-2.81B | -52.64%-1.04B | -27.15%-3.22B | -36.23%-940M | -50.81%-929M | -12.88%-666M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -107.22%-11.92B | 413.90%614.06B | 129.60%30.93B | -798.18%-87.03B | 1,550.27%505.12B | 454.15%165.04B | 9.56%-195.62B | -39.27%-104.5B | 81.12%-9.69B | 22.95%-34.83B |
| Net cash flow | ||||||||||
| Beginning cash position | -10.92%335.69B | 19.26%376.84B | -33.48%253.98B | -7.50%333.99B | 79.38%561.49B | 19.26%376.84B | -3.11%315.99B | 9.02%381.82B | 13.44%361.07B | 3.67%313.01B |
| Current changes in cash | -123.44%-38.67B | -224.40%-59.27B | 794.38%80.75B | -313.83%-75.92B | -663.01%-229.03B | 1,075.16%164.94B | 324.03%47.64B | 71.83%-11.63B | 34.99%35.51B | 109.29%40.68B |
| Effect of exchange rate changes | -70.02%5.91B | 37.12%18.11B | -85.62%957M | 72.30%-4.09B | -79.16%1.54B | 41.37%19.71B | 18.74%13.21B | -5.62%6.65B | -362.94%-14.76B | 340.94%7.38B |
| End cash Position | -46.05%302.93B | -10.92%335.69B | -10.92%335.69B | -33.48%253.98B | -7.50%333.99B | 79.38%561.49B | 19.26%376.84B | 19.26%376.84B | 9.02%381.82B | 13.44%361.07B |
| Free cash flow | -186.63%-11.94B | -62.39%89.98B | -40.49%52.06B | -29.93%36.14B | -91.46%5.94B | -113.62%-4.17B | 32.17%239.23B | 179.35%87.47B | -11.33%51.58B | -2.44%69.6B |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data